Intrathecal Baclofen Infusion-Botulinum Toxin Combined Treatment Efficacy in the Management of Spasticity due to Cerebral Palsy.

Riccardo MarvulliGiuseppa LagioiaGiancarlo IanieriLucrezia Dell'OlioAlessandra ZonnoMariagrazia RiccardiRosa Bianca SinisiLaura Belinda RizzoGiacomo FarìMarisa MegnaMaurizio Ranieri

Published in: CNS & neurological disorders drug targets (2024)

This study demonstrated the efficacy and safety of intrathecal baclofen infusion and botulinum toxin combined treatment in the management of spasticity, pain, quality of life, and selfcare in CP patients.

Keyphrases

botulinum toxin
cerebral palsy
end stage renal disease
low dose
spinal cord injury
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
spinal cord
neuropathic pain